drugset / Trial / NCT03937843
Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma
Phase 2
Active not recruiting
135 enrolled
Swiss Cancer Institute
German Testicular Cancer Study Group · collab
NaSingle-groupOpen-labelTreatment
Summary
The trial investigates a stage-adapted (stage IIA or IIB) de-escalation of the standard treatments in the context of a multimodality treatment with chemo- and radiotherapy in seminoma patients. The goal is to safely de-escalate treatment while maintaining/enhancing efficacy, which is not a standard practice yet.
Timeline
- Start
- 2019-07-29
- Primary completion
- 2026-12-31
- Completion
- 2046-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | 7 unknown | Intravenous |
| Subject | Cisplatin | Other / unclassified | 20 mg/m2 | Intravenous |
| Subject | Etoposide | Small molecule | 100 mg/m2 | Intravenous |